Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Internal Medicine

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2796.2011.02455.xPMID 21929694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge

  2011cited by this paper
• Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.

  2011cited by this paper
• Extreme Genetic Divergence Is Required for Coreceptor Switching in HIV-1 Subtype C

  2011cited by this paper
• Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions.

  2011cited by this paper
• Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease - indication of an evolving epidemic in West Africa

  2010cited by this paper
• An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

  2010cited by this paper
• Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children

  2010cited by this paper
• Maraviroc

  2010cited by this paper
• Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

  2010cited by this paper
• Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.

  2010cited by this paper
• Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.

  2010cited by this paper
• Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

  2010cited by this paper
• Clarifying the role of G protein signaling in HIV infection: new approaches to an old question.

  2010cited by this paper
• A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5

  2010cited by this paper
• A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors

  2009cited by this paper
• Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry

  2009cited by this paper
• Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates

  2009cited by this paper
• Adaptation of HIV-1 to human leukocyte antigen class I

  2009cited by this paper
• Genetic correlates of protection against HIV infection: the ally within

  2009cited by this paper
• Chemokine Coreceptor Signaling in HIV-1 Infection and Pathogenesis

  2009cited by this paper
• Structure-Function Analysis of Human Immunodeficiency Virus Type 1 gp120 Amino Acid Mutations Associated with Resistance to the CCR5 Coreceptor Antagonist Vicriviroc

  2009cited by this paper
• Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa

  2008cited by this paper
• Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists

  2008cited by this paper
• Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

  2008cited by this paper
• Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection

  2008cited by this paper
• Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.

  2008cited by this paper
• Maraviroc: The First of a New Class of Antiretroviral Agents

  2008cited by this paper
• The challenge of HIV-1 subtype diversity.

  2008cited by this paper
• The challenge of HIV-1 subtype diversity.

  2008cited by this paper
• Cofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot study

  2008cited by this paper
• Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression

  2008cited by this paper
• HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children

  2008cited by this paper
• HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells.

  2008cited by this paper
• Frequent Intrapatient Recombination between Human Immunodeficiency Virus Type 1 R5 and X4 Envelopes: Implications for Coreceptor Switch

  2007cited by this paper
• Relation Between Chemokine Receptor Use, Disease Stage, and HIV-1 Subtypes A and D: Results From a Rural Ugandan Cohort

  2007cited by this paper
• HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?

  2007cited by this paper
• Efficient Capture of Antibody Neutralized HIV-1 by Cells Expressing DC-SIGN and Transfer to CD4+ T Lymphocytes12

  2007cited by this paper
• Resistance to CCR5 antagonists

  2007cited by this paper
• The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness

  2006cited by this paper
• Human immunodeficiency virus type 1 (HIV‐1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G

  2006cited by this paper
• Dendritic-cell interactions with HIV: infection and viral dissemination

  2006cited by this paper
• Differential Pathogenesis of Primary CCR5-Using Human Immunodeficiency Virus Type 1 Isolates in Ex Vivo Human Lymphoid Tissue

  2005cited by this paper
• Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression

  2005cited by this paper
• The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility

  2005cited by this paper
• Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.

  2005cited by this paper
• The HIV coreceptor switch: a population dynamical perspective.

  2005cited by this paper
• Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.

  2005cited by this paper
• Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 Phenotype

  2004cited by this paper
• The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection

  2004cited by this paper
• Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation.

  2004cited by this paper
• The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

  2003cited by this paper
• Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4

  2003cited by this paper
• Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.

  2003cited by this paper
• Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C

  2003cited by this paper
• HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use

  2003cited by this paper
• Cell turnover and cell tropism in HIV-1 infection.

  2002cited by this paper
• Characterization of Full-Length HIV Type 1 Subtype C Sequences from South Africa

  2001cited by this paper
• Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue.

  2001cited by this paper
• T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).

  2000cited by this paper
• Molecular modeling and site‐directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction

  2000cited by this paper
• Occurrence of Additional NF-kappaB-Binding Motifs in the Long Terminal Repeat Region of South African HIV Type 1 Subtype C Isolates

  2000cited by this paper
• Chemokines and their receptors in lymphocyte traffic and HIV infection.

  2000cited by this paper
• A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression

  2000cited by this paper
• Phenotypic Characteristics of Human Immunodeficiency Virus Type 1 Subtype C Isolates of Ethiopian AIDS Patients

  1999cited by this paper
• Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function*

  1999cited by this paper
• Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection

  1999cited by this paper
• Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.

  1999cited by this paper
• HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.

  1999cited by this paper
• Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.

  1999cited by this paper
• Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.

  1998cited by this paper
• Increased sensitivity of

  1998cited by this paper
• A new classification for HIV-1

  1998cited by this paper
• In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression

  1997cited by this paper
• Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.

  1997cited by this paper
• Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1

  1997cited by this paper
• The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

  1997cited by this paper
• Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

  1997cited by this paper
• Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)

  1997cited by this paper
• Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals

  1997cited by this paper
• Multiple Extracellular Elements of CCR5 and HIV-1 Entry: Dissociation from Response to Chemokines

  1996cited by this paper
• CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

  1996cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.

  1996cited by this paper
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

  1996cited by this paper
• HIV-1 subtype and second-receptor use

  1996cited by this paper
• CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

  1996cited by this paper
• Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity

  1996cited by this paper
• Lower prevalence and incidence of HIV‐1 syncytium‐inducing phenotype among injecting drug users compared with homosexual men

  1995cited by this paper
• Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.

  1995cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand

  1995cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.

  1994cited by this paper
• MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection

  1994cited by this paper
• Prognostic Value of HIV-1 Syncytium-Inducing Phenotype for Rate of CD4+ Cell Depletion and Progression to AIDS

  1993cited by this paper
• HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay

  1992cited by this paper
• Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

  1989cited by this paper
• Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates

  1988cited by this paper
• Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex

  1988cited by this paper

• Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage

  2022cites this paper
• Subtype-Dependent Co-receptor Tropism in Cuban HIV-1-Infected Patients: Implications for Maraviroc Treatment.

  2021cites this paper
• Low-Bias RNA Sequencing of the HIV-2 Genome from Blood Plasma

  2018cites this paper
• Natural alteration of HIV-1 co-receptor tropism by contemporaneous HIV-2 infection

  2018cites this paper
• Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak

  2018cites this paper
• Distinct antibody-mediated selection in a narrow-source HIV-1 outbreak among Chinese former plasma donors

  2017cites this paper
• Antiretroviral Treatment at Ethiopian Health Centers

  2017cites this paper
• Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency

  2016cites this paper
• Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing

  2016cites this paper
• The evolution of HIV-1 interactions with coreceptors and mannose C-type lectin receptors.

  2015cites this paper
• Toll-Like Receptor 3 Signalling UpRegulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD 4 ( + ) T Cells

  2014cites this paper
• Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies

  2014cites this paper
• Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4+ T Cells

  2014cites this paper
• Correction: HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG

  2013cites this paper
• Rôle des polymorphismes dans la région C-Terminale de l'enveloppe du VIH dans l'infection de cellules primaires

  2013influential citation
• HIV-1 Tropism Determination Using a Phenotypic Env Recombinant Viral Assay Highlights Overestimation of CXCR4-Usage by Genotypic Prediction Algorithms for CRRF01_AE and CRF02_AG

  2013cites this paper
• The frantic play of the concealed HIV envelope cytoplasmic tail

  2013cites this paper
• From The Department of Microbiology, Tumor and Cell Biology Karolinska Institutet, Stockholm, Sweden STUDIES ON THE HOST IMMUNE RESPONSE DURING PULMONARY TB AND DURING M. TUBERCULOSIS/HIV CO-INFECTION

  2012cites this paper
• ELICITATION AND ENHANCEMENT OF T AND B CELL RESPONSES

  2012cites this paper
• HIV-1, HIV-2 and other Sexually Transmitted Infections in Guinea-Bissau, West Africa

  2012cites this paper
• Impact of Mycobacterium tuberculosis and HIV-1 on innate immune mechanisms

  2012cites this paper
• Intrahost evolution of HIV-1 phenotypes

  2012cites this paper
• Chronic immune activation and lymphocyte apoptosis during HIV-1 infection

  2012cites this paper
• Dynamics of HIV coreceptors and their utilization by plasma and cerebrospinal fluid HIV-1 isolates

  2012cites this paper
• Towards a world free from HIV and AIDS?

  2011cites this paper